SCHEMBL8482176

SCHEMBL8482176

NCCOCC(O)c1ccccc1

nearest known ligand 0.50

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
AOC3 Q16853 5/20 0.46
LMNA P02545 1/20 0.45
KDM4E B2RXH2 2/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
HRH1 P35367 2/20 0.42
TAAR1 Q96RJ0 2/20 0.41
BCAT2 O15382 1/20 0.41
HTR2A P28223 2/20 0.40
SLC6A2 P23975 1/20 0.40
SLC6A4 P31645 1/20 0.40
SLC6A3 Q01959 1/20 0.40
RIPK1 Q13546 1/20 0.39
CYP1A2 P05177 1/20 0.38
CYP2D6 P10635 1/20 0.38
PKM P14618 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4426990 0.83 LMNA (0.56) AOC3LMNAKDM4EL3MBTL1BCAT2
SCHEMBL8151932 0.82 LMNA (0.47) AOC3LMNAKDM4EL3MBTL1HRH1
SCHEMBL11600545 0.81 LMNA (0.45) AOC3LMNAKDM4EL3MBTL1BCAT2
SCHEMBL5214978 0.81 LMNA (0.45) AOC3LMNAKDM4EL3MBTL1RIPK1
SCHEMBL10511898 0.81 LMNA (0.55) AOC3LMNAKDM4EL3MBTL1RIPK1
SCHEMBL10615156 0.79 LMNA (0.44) AOC3LMNAKDM4EL3MBTL1HRH1
SCHEMBL28207428 0.79 LMNA (0.44) AOC3LMNAKDM4EL3MBTL1HRH1
SCHEMBL12222364 0.79 LMNA (0.48) AOC3LMNAKDM4EL3MBTL1RIPK1
SCHEMBL8837196 0.79 LMNA (0.44) AOC3LMNAKDM4EL3MBTL1HRH1
SCHEMBL10512429 0.78 LMNA (0.52) AOC3LMNAKDM4EL3MBTL1RIPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5872117-A TREATING CEREBROVASCULAR DEMENTIA, SENILE DEMENTIA, ALZHEIMER'S DEMENTIA, SEQUELAE OF ISCHEMIC ENCEPHALOPATHY AND CEREBRAL APOPLEXY TOYAMA CHEMICAL CO., LTD. (JP) 1999-02-16 US disclosed
US-5719150-A ALZHEIMER'S DISEASE TOYAMA CHEMICAL CO., LTD. (JP) 1998-02-17 US disclosed
US-5658904-A COGNITION ACTIVATORS; BRAIN DISORDERS; ALZHEIMER*S DISEASE TOYAMA CHEMICAL CO., LTD. (JP) 1997-08-19 US disclosed
US-5612381-A 1,2-ethanediol derivative and salt thereof process for producing the same, and cerebral function-improving agent comprising the same TOYAMA CHEMICAL CO., LTD. (JP) 1997-03-18 US disclosed
EP-0587193-B1 1,2-Ethanediol derivative and salt thereof, process for producing the same, and cerebral function-improving agent comprising the same TOYAMA CHEMICAL CO LTD (JP) 1997-01-02 EP disclosed
US-5472984-A 1,2-ethanediol derivative and salt thereof and cerebral function-improving agent comprising the same TOYAMA CHEMICAL CO., LTD. (JP) 1995-12-05 US disclosed
EP-0589484-A1 1,2-Ethanediol derivative and salt thereof, process for producing the same, and cerebral function-improving agent comprising the same TOYAMA CHEMICAL CO., LTD. (JP) 1994-03-30 EP disclosed
EP-0587194-A1 2-(Heterocycloalkoxy)-1-(subst.-phenyl)-ethanol derivatives as cerebral function improving agents TOYAMA CHEMICAL CO., LTD. (JP) 1994-03-16 EP disclosed
EP-0587193-A1 1,2-Ethanediol derivative and salt thereof, process for producing the same, and cerebral function-improving agent comprising the same TOYAMA CHEMICAL CO., LTD. (JP) 1994-03-16 EP disclosed
US-5280032-A 1,2-ethanediol derivative and salt thereof, process for producing the same, and cerebral function-improving agent comprising the same TOYAMA CHEMICAL CO., LTD. (JP) 1994-01-18 US disclosed
EP-0383281-A1 1,2-ethanediol derivative and salt thereof, process for producing the same, and cerebral function-improving agent comprising the same TOYAMA CHEMICAL CO., LTD. (JP) 1990-08-22 EP disclosed